» Articles » PMID: 27175570

Ophiopogonin B Induces Apoptosis, Mitotic Catastrophe and Autophagy in A549 Cells

Overview
Journal Int J Oncol
Specialty Oncology
Date 2016 May 14
PMID 27175570
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Ophiopogonin B (OP-B), a saponin compound isolated from Radix Ophiopogon japonicus, was verified to inhibit cell proliferation in numerous non-small cell lung cancer (NSCLC) cells in our previous study. However, the precise mechanisms of action have remained unclear. In the present study, we mainly investigated the effects of OP-B on adenocarcinoma A549 cells to further elaborate the underlying mechanisms of OP-B in different NSCLC cell lines. Detection by high content screening (HCS) and TUNEL assay verified that OP-B induced apoptosis in this cell line, while detection of Caspase-3, Bcl-2 and Bax showed that OP-B induced cell death was caspase and mitochondrial independent. Further experiments showed that OP-B induced cell cycle arrest in the S and G2/M phases by inhibiting the expression of Myt1 and phosphorylation of Histone H3 (Ser10), which resulted in mitotic catastrophe in the cells. Transmission electron microscopy (TEM) observation of cell micro-morphology combined with detection of Atgs by western blot analysis showed that OP-B induced autophagy in this cell line. Autophagy inhibition by the lysosome inhibitor CQ or Beclin1-siRNA knockdown both attenuated cell viability, demonstrated that autophagy also being the vital reason resulted in cell death. More importantly, the xenograft model using A549 cells provided further evidence of the inhibition of OP-B on tumor proliferation. Immunohistochemistry detection of LC3 and Tunel assay both verified that high dose of OP-B (75 mg/kg) induced autophagy and apoptosis in vivo, and western blot detection of p-Histone H3 (Ser10), Survivin and XIAP further indicated the molecular mechanism of OP-B in vivo. As our findings revealed, multiple types of cell death overlapped in OP-B treated A549 cells, it displayed multitarget characteristics of the compounds extracted from the Chinese herbal, which may be used as candidate anticancer medicine in clinic.

Citing Articles

TCM targets ferroptosis: potential treatments for cancer.

Qin L, Zhong Y, Li Y, Yang Y Front Pharmacol. 2024; 15:1360030.

PMID: 38738174 PMC: 11082647. DOI: 10.3389/fphar.2024.1360030.


Ferroptosis in lung cancer: a novel pathway regulating cell death and a promising target for drug therapy.

Xing N, Du Q, Guo S, Xiang G, Zhang Y, Meng X Cell Death Discov. 2023; 9(1):110.

PMID: 37005430 PMC: 10067943. DOI: 10.1038/s41420-023-01407-z.


Abnormal expression of induces S-phase arrest and mitotic catastrophe in human T-lymphocyte leukemia.

Zamora Dominguez J, Olarte Carrillo I, Ruiz Ramos R, Ramos-Penafiel C, Jimenez Zamudio L, Garcia Latorre E Blood Res. 2023; 58(1):20-27.

PMID: 36632684 PMC: 10063590. DOI: 10.5045/br.2023.2022143.


Cell metabolomics study on the anticancer effects of against lung cancer cells using UHPLC/Q-TOF-MS analysis.

Liu Q, Shen J, Hong H, Yang Q, Liu W, Guan Z Front Pharmacol. 2022; 13:1017830.

PMID: 36188550 PMC: 9523105. DOI: 10.3389/fphar.2022.1017830.


Induction of Ferroptosis by Ophiopogonin-B Through Regulating the Gene Signature in NSCLC.

Li L, Gao Q, Wang J, Gu L, Li Z, Zhang S Front Oncol. 2022; 12:833814.

PMID: 35875069 PMC: 9299951. DOI: 10.3389/fonc.2022.833814.